Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose

ClinicalTrials.gov ID: NCT01439165

Public ClinicalTrials.gov record NCT01439165. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 19, 2026, 10:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID: NCT01439165
Recruitment status: Completed
Study type: Interventional
Phase: Phase 4
Lead sponsor: Sanofi Pasteur, a Sanofi Company; Industry
Enrollment: 1,330 participants

Conditions and interventions

Conditions

Interventions

Tetanus Toxoid, Diphtheria Toxoid and Pertussis Vaccine Biological
Tetanus and Diphtheria Toxoids Adsorbed For Adult Use Biological

Biological

Eligibility (public fields only)

Age range: 18 Years to 64 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 31, 2011
Primary completion: Nov 30, 2015
Completion: Jan 31, 2017
Last update posted: Apr 27, 2022

2011 – 2017

United States locations

U.S. sites: 31
U.S. states: 20
U.S. cities: 31

Facility	City	State	ZIP	Site status
Not listed	Huntsville	Alabama	35802	—
Not listed	Jonesboro	Arkansas	72401	—
Not listed	Little Rock	Arkansas	72205	—
Not listed	San Diego	California	92108	—
Not listed	Boulder	Colorado	80304	—
Not listed	Marietta	Georgia	30062	—
Not listed	Woodstock	Georgia	30189	—
Not listed	Peoria	Illinois	61602	—
Not listed	Mishawaka	Indiana	46545	—
Not listed	Louisville	Kentucky	40202	—
Not listed	Rockville	Maryland	20850	—
Not listed	Woburn	Massachusetts	01801	—
Not listed	Columbia	Missouri	65212	—
Not listed	St Louis	Missouri	63104	—
Not listed	Albuquerque	New Mexico	87108	—
Not listed	Brooklyn	New York	11201	—
Not listed	Ithaca	New York	14850	—
Not listed	Rochester	New York	14618	—
Not listed	Raleigh	North Carolina	27612	—
Not listed	Winston-Salem	North Carolina	27103	—
Not listed	Cincinnati	Ohio	45229	—
Not listed	Cleveland	Ohio	44121	—
Not listed	Clairton	Pennsylvania	15025	—
Not listed	Hershey	Pennsylvania	17033	—
Not listed	Latrobe	Pennsylvania	15650	—
Not listed	Pittsburgh	Pennsylvania	15224	—
Not listed	Syracuse	Utah	84075	—
Not listed	Virginia Beach	Virginia	23456	—
Not listed	Vancouver	Washington	98686	—
Not listed	Chippewa Falls	Wisconsin	54729	—
Not listed	Marshfield	Wisconsin	54449	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01439165, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 27, 2022 · Synced May 19, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01439165 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →